- Home
- AYRO vs EVOK Comparison
AYRO vs EVOK Comparison
Compare AYRO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYRO
- EVOK
- Stock Information
- Founded
- AYRO 2017
- EVOK 2007
- Country
- AYRO United States
- EVOK United States
- Employees
- AYRO N/A
- EVOK N/A
- Industry
- AYRO Telecommunications Equipment
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- AYRO Consumer Discretionary
- EVOK Health Care
- Exchange
- AYRO Nasdaq
- EVOK Nasdaq
- Market Cap
- AYRO 4.3M
- EVOK 4.2M
- IPO Year
- AYRO N/A
- EVOK 2013
- Fundamental
- Price
- AYRO $0.49
- EVOK $3.14
- Analyst Decision
- AYRO
- EVOK
- Analyst Count
- AYRO 0
- EVOK 0
- Target Price
- AYRO N/A
- EVOK N/A
- AVG Volume (30 Days)
- AYRO 84.7K
- EVOK 14.8K
- Earning Date
- AYRO 05-23-2025
- EVOK 05-20-2025
- Dividend Yield
- AYRO N/A
- EVOK N/A
- EPS Growth
- AYRO N/A
- EVOK N/A
- EPS
- AYRO N/A
- EVOK N/A
- Revenue
- AYRO $63,777.00
- EVOK $10,249,415.00
- Revenue This Year
- AYRO N/A
- EVOK $58.84
- Revenue Next Year
- AYRO N/A
- EVOK $58.11
- P/E Ratio
- AYRO N/A
- EVOK N/A
- Revenue Growth
- AYRO N/A
- EVOK 97.84
- 52 Week Low
- AYRO $0.38
- EVOK $1.94
- 52 Week High
- AYRO $1.29
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- AYRO 45.92
- EVOK 59.77
- Support Level
- AYRO $0.44
- EVOK $3.00
- Resistance Level
- AYRO $0.67
- EVOK $3.32
- Average True Range (ATR)
- AYRO 0.05
- EVOK 0.24
- MACD
- AYRO 0.00
- EVOK 0.11
- Stochastic Oscillator
- AYRO 21.74
- EVOK 79.55
About AYRO AYRO Inc.
AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.